• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025

    5/12/25 1:00:00 AM ET
    $ZEAL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ZEAL alert in real time by email

    Press release – No. 8 / 2025

    Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025

    Copenhagen, Denmark, May 12, 2025 – Zealand Pharma A/S (NASDAQ:ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company will participate in the following healthcare investor conferences in May and June 2025:

    • Bank of America Global Healthcare Conference, May 13-15 in Las Vegas

    David Kendall, Executive Vice President and Chief Medical Officer, will present on Wednesday, May 14 at 8:00am PT (5:00pm CET).

    A live audio webcast of the presentation will be available at https://bofa.veracast.com/webcasts/bofa/healthcare2025/id0V27z5.cfm.

    • Berenberg European Conference, May 20-22 in New York

    Adam Steensberg, President and Chief Executive Officer, to host investor meetings on Tuesday, May 20.

    • Barclays European Leadership Conference, May 22 in London

    David Kendall, Executive Vice President and Chief Medical Officer to participate in a panel discussion about obesity on Thursday, May 22 at 11:30am UKT (12:30pm CET). The panel will not be webcast.  

    • Jefferies Global Healthcare Conference, June 3-5 in New York

    Anna Krassowska, Vice President, Investor Relations & Corporate Communications to participate in a fireside chat on Thursday, June 5 at 11:40am ET (5:40pm CET). The fireside chat will not be webcast.

    • Goldman Sachs Annual Global Healthcare Conference, June 9-11 in Miami

    Adam Steensberg, President and Chief Executive Officer, to participate in fireside chat on Wednesday, June 11 at 4:00pm ET (10:00pm CET).

    A webcast of the fireside chat will be available at https://www.zealandpharma.com/events/ in the coming weeks, where replays of all webcasts are also archived.

    About Zealand Pharma A/S

    Zealand Pharma A/S (NASDAQ:ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.

    Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma's business and activities, please visit www.zealandpharma.com.

    Contacts

    Adam Lange (Investors)

    Vice President, Investor Relations

    [email protected]

    Neshat Ahmadi (Investors)

    Investor Relations Manager

    [email protected]

    Anna Krassowska, PhD (Investor and Media)

    Vice President, Investor Relations & Corporate Communications

    [email protected]



    Primary Logo

    Get the next $ZEAL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ZEAL

    DatePrice TargetRatingAnalyst
    3/5/2024Buy
    Berenberg
    8/8/2023Equal-Weight
    Morgan Stanley
    11/16/2022Overweight → Equal-Weight
    Morgan Stanley
    1/11/2022Hold → Buy
    Jefferies
    More analyst ratings